Intravenous immunoglobulin therapy for dengue capillary leak syndrome in a renal allograft recipient

Pulmonary Capillary Leak Syndrome

Intravenous immunoglobulin therapy for Stevens-Johnson syndrome.

Stevens-Johnson syndrome (SJS) is an acute mucocutaneous disorder that can be associated with considerable morbidity. Several previous reports, all involving either adults with acquired immunodeficiency syndrome or children, suggest that intravenous immunoglobulin may be an effective treatment for SJS. We report a case of SJS in an immunocompetent adult whose condition improved dramatically aft...

Intravenous immunoglobulin therapy for Miller Fisher syndrome.

We analyzed clinical recovery of 92 patients with Miller Fisher syndrome who had been treated with IV immunoglobulin (IVIg; n = 28), plasmapheresis (n = 23), and no immune treatment (n = 41). IVIg slightly hastened the amelioration of ophthalmoplegia and ataxia, but the times of the disappearances of those symptoms were similar among three groups. In Miller Fisher syndrome, IVIg and plasmaphere...

Successful treatment of systemic capillary leak syndrome with intravenous immunoglobulins.

posteriormente leveriracetam y gabapentina en el manejo del status epiléptico en pacientes con PAI. Sin embargo, ningún fármaco debiera ser descartado por completo si su uso resultase esencial. Con frecuencia tras el diagnóstico nos encontramos con fármacos considerados no seguros sin efectos adversos. No obstante, es importante recordar su posible interacción futura con otros fármacos que pudi...

Tophaceous gout in a renal allograft recipient

A 65-year-old female received a renal transplantation 3 years ago, and her maintenance immunosuppressive regimen included prednisolone 5 mg once daily (0.1 mg/kg/ day), mycophenolate mofetil 1 g twice daily and cyclosporin 125 mg twice daily (5 mg/kg/day) with average trough serum levels of cyclosporine between 200 and 300 ng/mL since 3 months after renal transplantation. Her first episode of g...